Not sure what the tag is for, as even the arrow doesn't make it any clearer.
Adults - yes
Clinical trial - yes
SR-aGvHD - yes
Unless you are trying to say that patients rather wait a few extra days until it is certain that they won't respond to steroids to participate in MSB's trial?
Again, SR-aGvHD (MSB) vs HR-aGvHD (CYP). That difference could be up to 72h, in a disease where MSC trials thus far seem to suggest that the earlier the treatment starts, the better the chances for the patient (observation made by Galipeau when talking about MSB's 001 trial design).
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $37.28M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.0¢ | 16.5¢ | $39.66K | 238.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 277684 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 14285 | 1 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |